These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 2772475)
1. Second International Symposium on New Quinolones. Geneva, Switzerland, 25-27 August 1988. Rev Infect Dis; 1989; 11 Suppl 5():S897-1431. PubMed ID: 2772475 [No Abstract] [Full Text] [Related]
2. International Symposium on New Quinolones. Geneva, Switzerland, July 17-19, 1986. Proceedings. Rev Infect Dis; 1988; 10 Suppl 1():S1-271. PubMed ID: 3347810 [No Abstract] [Full Text] [Related]
3. Proceedings of the 5th International Symposium on New Quinolones. Singapore, August 25-27, 1994. Drugs; 1995; 49 Suppl 2():1-505. PubMed ID: 8549274 [No Abstract] [Full Text] [Related]
4. Lomefloxacin (NY-198 or SC 47111): in vitro evaluations of a new fluoroquinolone. Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):1S-105S. PubMed ID: 2791492 [No Abstract] [Full Text] [Related]
5. 7th International Symposium on New Quinolones. Edinburgh, UK, 10-12 June 2001. Abstracts. J Antimicrob Chemother; 2001 Jun; 47 Suppl 1():1-54. PubMed ID: 11439973 [No Abstract] [Full Text] [Related]
6. Symposium: First Canadian Quinolone Conference and Workshop. December 1987, Lake Louise, Alberta. Proceedings. Clin Invest Med; 1989 Feb; 12(1):1-75. PubMed ID: 2920478 [No Abstract] [Full Text] [Related]
7. New quinolones in clinical practice. MacGowan AP Hosp Med; 1999 Apr; 60(4):309. PubMed ID: 10396443 [No Abstract] [Full Text] [Related]
8. [The role of the new quinolones in the treatment and prevention of tuberculosis and other infections caused by mycobacterium]. Ciruelos E; Zalazaín R; Sobradillo V Enferm Infecc Microbiol Clin; 1999; 17 Suppl 1():34-8. PubMed ID: 10563109 [No Abstract] [Full Text] [Related]
14. Lomefloxacin sensitivities. Smith JM; Hashmi ZS N Z Med J; 1989 Jul; 102(872):391. PubMed ID: 2797570 [No Abstract] [Full Text] [Related]
15. [The place of the new quinolones in the guidelines on the treatment of community-acquired pneumonia]. Dorca J Arch Bronconeumol; 1999 May; 35 Suppl 3():77-80. PubMed ID: 10410230 [No Abstract] [Full Text] [Related]
16. New antibiotics: carbapenems, monobactams and quinolones. Amin NM Am Fam Physician; 1988 Oct; 38(4):125-34. PubMed ID: 3051970 [TBL] [Abstract][Full Text] [Related]
17. [Are quinolones the drugs of choice in pneumonia caused by microorganisms of Legionella genus?]. Bouza Santiago E; Rodríguez-Créixems M Enferm Infecc Microbiol Clin; 1999; 17 Suppl 1():19-23. PubMed ID: 10563106 [No Abstract] [Full Text] [Related]